| Name | Title | Contact Details |
|---|---|---|
Heather Ata |
Chief Marketing Officer | Profile |
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.
Afferent Pharmaceuticals, Inc. is a leader in the development of novel, selective drugs for the treatment of a range of debilitating neurogenic disorders. These disorders affect millions of patients who suffer from chronic respiratory and urologic sensory pathologies as well as chronic pain, and who have limited, if any, treatment options. These chronic disorders arise when certain nerve fibers become hyper-sensitized as a result of inflammation, distress, infection or tissue injury, and sometimes remain chronically sensitized for months or even years.
Renaissance Resource Associate is a Tacoma, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Akeso Care Management is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
With nearly 8,500 employees, more than 1,500 medical staff members, and 837 licensed beds, Bronson Healthcare is the largest employer and leading healthcare system in southwest Michigan. It offers a full range of services from primary care to critical care across more than 100 locations. Key member organizations include: Bronson Methodist Hospital, Bronson Battle Creek, Bronson LakeView Hospital, Bronson South Haven Hospital, Bronson Medical Group, Bronson at Home, Bronson Commons, Bronson Athletic Club, Bronson Wellness Center and the Bronson Health Foundation.